> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-176/
- Published: 2018-04-22T12:00:00.000Z
- Updated: 2026-09-15T00:00:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141278

[**Guide on GMPs for Active Pharmaceutical Ingredients**](https://www.fdaweb.com/guide-on-gmps-for-active-pharmaceutical-ingredients/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients: Questions and Answers.” 04/20/2018

[**Draft Guide on Inhalation Drug Products**](https://www.fdaweb.com/draft-guide-on-inhalation-drug-products/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products — Quality Considerations.” 04/19/2018

[**Ultrasonic Diathermy Devices Policy Clarification**](https://www.fdaweb.com/ultrasonic-diathermy-devices-policy-clarification/)  
*Federal Register* notice: FDA makes available a guidance entitled “Policy Clarification and Premarket Notification \[510(k)\] Submissions for Ultrasonic Diathermy Devices; Guidance for Industry and Food and Drug Administration Staff.” 04/17/2018

[**Draft Guide on Streamlined Approach for Oncology IVDs**](https://www.fdaweb.com/draft-guide-on-streamlined-approach-for-oncology-ivds/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination.” 04/17/2018

[**Guide on Special Protocol Assessments**](https://www.fdaweb.com/guide-on-special-protocol-assessments/)  
*Federal Register* notice: FDA makes available a guidance entitled “Special Protocol Assessment (SPA)” that provides information about the procedures and general policies adopted by CDER/CBER for such assessments. 04/17/2018

[**Guide on Caffeine in Dietary Supplements**](https://www.fdaweb.com/guide-on-caffeine-in-dietary-supplements/)  
*Federal Register* notice: FDA makes available a guidance on “Highly Concentrated Caffeine in Dietary Supplements.” 04/17/2018